Merck Could Find New Keytruda Biomarkers With NanoString
This article was originally published in The Pink Sheet Daily
Executive Summary
Initial work seeks to identify biomarkers for bladder, gastric and head-and-neck cancer, as well as one that might work where PD-L1 expression is not predictive of treatment effect, such as advanced melanoma.